checkAd

     118  0 Kommentare Ziopharm Oncology Announces Election of Robert Postma to its Board of Directors - Seite 2

    Investor Relations Contacts:        
    Adam D. Levy, Ph.D., MBA                                                        
    EVP, Investor Relations and Corporate Communications
    T: 508.552.9255
    E: alevy@ziopharm.com

    Lesen Sie auch

    Media Relations Contact:
    LifeSci Communications:
    Patrick Bursey
    T: 646.876.4932
    E: pbursey@lifescicomms.com


    Seite 2 von 2



    Diskutieren Sie über die enthaltenen Werte



    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors


    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Ziopharm Oncology Announces Election of Robert Postma to its Board of Directors - Seite 2 BOSTON, Feb. 05, 2021 (GLOBE NEWSWIRE) - Ziopharm Oncology, Inc. (“Ziopharm” or “the Company”) (Nasdaq:ZIOP) today announced the election of Robert Postma to its Board of Directors (the “Board”), effective immediately. Mr. Postma is the Founder of …